pipette
ESEspañol

CLN6 is a glycerophosphoglycerol epimerase in bis(monoacylglycero)phosphate biosynthesis

P. K. Sheokand, A. M. James, C. Posern, A. Singh Sahrawat, J. Breithofer, J. Ganellin, M. K. Proulx, S. K. Leese, K. Turner, D. Lacabanne, D. Bulfon, B. Jenkins, J. van der Kleij, H. E. Johnston, S. O. Lord, M. K. Basran, C. S. Yu, C. D. Booth, J. M. Weimer, A. Koulman, M. Jäättelä, E. R. S. Kunji, D. N. Palmer, N. L. Mitchell, J. Prudent, R. Zimmermann, K. Gruber, A. Schulz, M. P. Murphy, K. Petkevicius

Preprint

In the authors' words

Lysosomal catabolism depends on bis(monoacylglycero)phosphate (BMP), a phospholipid with atypical S,S stereochemistry of unknown biosynthetic origin. CLN8 and CLN5 catalyze sequential acylation steps in BMP synthesis, and their loss of function causes Batten disease, a group of inherited neurodegenerative lysosomal storage disorders. Here we identify CLN6, a biochemically uncharacterized endoplasmic reticulum protein whose loss also causes Batten disease, as the calcium-dependent glycerophosphoglycerol epimerase that establishes BMP stereochemistry upstream of CLN8. CLN6 deficiency depletes BMP in cells, mice, and patient lysosomes, and reduces lysosomal hydrolase levels. BMP-precursor supplementation bypasses CLN6, restores BMP and increases hydrolase abundance in CLN6-deficient cells and mice. These findings place three Batten disease proteins in a single biosynthetic pathway and reveal BMP deficiency as a reversible cause of disrupted lysosomal hydrolase homeostasis.

Main resultThe abstract does not state a limitation.

Appeared: Saturday, October 10. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.07.757350